American Express National Bank Expands Beyond Credit Cards with HighYield Accounts and NoFee Banking for 2026 Broadcom Meta and Industry Partners Launch 125 Million Semiconductor Research Hub at UCLA Teledyne Technologies Stock Outlook Wall Street Sentiment Mixed Amid Diverse Portfolio AI Casts Shadow Over Japans NearRecord Hiring of New Graduates SP 500 Edges Higher as Healthcare and Tech Lead Utilities Slip Microns Monthly Surge Echoes 1987 Rally Analysts Flag Potential Value Opportunity Silvercrest Asset Management Group Inc Q1 2026 Earnings EPS Misses Estimates Stock Declines Braze Inc Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction OPXS Q1 2026 Earnings Positive EPS of 003 Reported Amid Limited Disclosure CGBD Q1 2026 Earnings Slight EPS Miss Amid Stable Portfolio Performance Compugen Ltd Q1 2026 Earnings Narrowing Losses but Misses Estimates POCI Q1 2026 Earnings Narrowing Loss Amidst Operational Progress Arhaus Inc ARHS Rebounds 4 from Support Testing Key Resistance Zone Gabelli MultiMedia Trust GGT Holds Steady Near Support as Consolidation Continues Yum Brands YUM Creeps Higher as Stock Tests Key Resistance Area Kayne Anderson Energy Infrastructure Fund KYN Nears Support After Modest Decline AllianceBernstein Global High Income Fund AWF Edges Higher on Moderate Volume SP 500 Edges Higher as Healthcare Tech Lead Communication Services Lags OneSpan OSPN Q1 2026 Earnings EPS Surpasses Estimates Stock Gains on Profitability Beat FiEE Inc FIEE Edges Lower as Stock Tests Key Support Around 580 Oxford Lane Capital Corp Preferred Stock Shares 600 Series 2029 OXLCO Q4 2025 Earnings EPS Misses Estimates Despite Solid Operating Results VLN Q1 2026 Earnings NarrowerThanExpected Loss Drives Share Rally PHIO Q1 2026 Earnings EPS Misses Estimates as ResearchFocused Biotech Maintains Development Pace UTSI Q4 2019 Earnings Significant EPS Miss Highlights Operational Challenges KUST Q4 2025 Earnings EPS Misses Estimates by a Wide Margin Amid Operational Challenges AMTD Q4 2020 Earnings Massive EPS Beat Highlights Strong Operational Performance Crescent Biopharma CBIO Q1 2026 Earnings Narrower Loss Beats Estimates Shares Edge Lower